News

The IL-17A-targeting biologic has now been indicated for pediatric plaque psoriasis—marking its fourth indication for patients with chronic diseases.

Patients with TED might be particularly vulnerable to COVID-19 infections.

A new Emory University-led study is shedding more light on the impact mental stress can have on cardiovascular health.

The intervention is no better than usual care at improving the mood or burden of those caring for adults with advanced heart failure, according to new findings.

A discussion about a recent scientific statement outlining the treatment of coronary artery disease in type 2 diabetics from the AHA with statement co-author Deepak Bhatt, MD.

A new summary of recent cow's milk allergy guidelines show conlficting consensus on identifying and caring for infantile allergic symptoms.

Medical staff members with insomnia also had higher levels of depression than healthcare workers without insomnia.

Patients who do not have the coronavirus should continue IBD therapies, including all scheduled infusions.

Investigators compare cesarean delivery to vaginal delivery to understand the association between delivery type and obesity and type 2 diabetes.

Investigators from Saint Louis University discuss a new comparison of 2 drug classes that could reduce the risk of adverse cardiovascular events.

A new study analyzing at-home blood pressure devices available for purchase online has found most are not validated—bringing their accuracy into question.

A new scientific statement from the AHA offers guidance to clinicians tasked with treating CAD in patients with type 2 diabetes.

A long-form discussion with a pair of professors and pediatricians from the University of Florida College of Medicine.

VR is a promising learning strategy to prepare students to be part of a collaborative workforce.

A discussion with Paul W. Armstrong of the University of Alberta, on the pandemic's effect on common ICU conditions.

The drug is the first of its kind to be indicated for the genetic nervous disorder.

Clinical investigator and allergist Jonathan Corren, MD, shares insight on the TSLP inhibitor.

Filip Janku, MD, PhD, discusses new post hoc analyses for the opioid receptor antagonist in advanced-illness patients.

New research is shining light on the use of eGFR as a biomarker for increased cardiovascular risk.

The findings can inform the development of health messaging tailored to older women with chronic conditions.

AXS-07 showed statistical significance for migraine pain freedom at 90 minutes, and at every time point after.

An interview with a pair of pediatricians and professors from the University of Florida College of Medicine discussing the use of telehealth in COVID-19.

Clinicians and patients alike must know of the uncommon but potentially life-threatening adverse events related to the drugs.

In a new study, investigators discover the hazard of depression increases with each BMI category.

Paul W. Armstrong, MD, joins to discuss the virtual cardiology sessions, as well as his team's new findings for vericiguat in high-risk heart failure.

New data in JAMA Ophthalmology is examining the impact of ocular injuries from the NEISS database.

Clinicians must be aware of the high prevalence of withdrawal to counsel patients and support those reducing their use of cannabis.

New data shows higher rates of cancer and cardiovascular disease deaths for patients with celiac disease.